RxDoctor Payments Data

Erin Sonneberg

Optometrist · Boynton Beach, FLNPI 1851422083

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $183 of the $291 with a category attached, or 62.8%. 6 manufacturers reported payments, led by Optos, Inc. at 37.2% of the total. Reporting peaked in 2019 at $121 and has fallen 50.8% since, to $60 in 2025. That places this record below the midpoint for optometrist clinicians in FL, where the typical reported total is $857.

$291in general payments, 2019–2025

Across 6 payments — averaging $48.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optos, Inc.$108
  • Topcon Healthcare, Inc.$68
  • Coopervision Inc.$60
  • Alcon$24
  • Novartis$17
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$13

What the payments were for

  • Food & beverage$18363%
  • Entertainment$10837%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$291 in reported general payments places this provider in the 25th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida

Medicare billing

Part B allowed, 2024
$119,891
Medicare patients
329
Services billed
1,254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate33$962
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha18$193

Paid to pharmacies, not to this prescriber.

Other optometrist in Boynton Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →